Bjørn-Eivind Kirsebom
Job description
Forskning, undervisning og veiledning innen klinisk nevropsykologi/nevrologi med spesielt fokus på demenssykdomer.
Leder Dementia Disease Initiation (DDI) avd. Tromsø.
Therese Händel,
Bjørn-Eivind Seljelid,
Carsten,
Linda,
Geir,
Peter
et al.:
New regression-based norms for the Trail Making Test on Norwegian older adults: Understanding the effect of education
The Clinical Neuropsychologist 2025 DOI
Anders,
Ron,
Kaj,
Bjørn-Eivind,
Per,
Jaka
et al.:
Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting
Journal of Alzheimer's Disease 2025 DOI
Fernando,
Bjørn-Eivind,
Yara,
Julia Kristine,
Lene,
Knut
et al.:
Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease
Neurology 2025 DOI
Ingrid Myrvoll,
Johan Jacob,
Ingvild Vøllo,
Erik,
Knut,
Santiago
et al.:
Norwegian normative data for regression-based D-KEFS color-word interference test derived measures and comparison to conventional contrast measures
Applied neuropsychology: Adult 2025 DOI
Stephanie,
Kaja,
Lene,
Berglind,
Jonas Alexander,
Geir
et al.:
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer’s disease
Brain Communications 2025 DOI
Wietse A.,
Julie E.,
Sebastiaan,
Chris,
Christine A.F. Von,
Mercè
et al.:
Depressive Symptoms and Amyloid Pathology
JAMA psychiatry 2025 DOI
Bjørn-Eivind,
Fernando,
Sinthujah,
Geir,
Ragnhild Eide,
Berglind
et al.:
Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity
Alzheimer's & Dementia 2025 DOI
Mathilde Suhr,
Monica Haraldseid,
Luiza,
Berglind,
Erik,
Nikias Ioannis
et al.:
Demographically unadjusted cognitive test scores may enhance the validity of mild cognitive impairment as a dementia prodrome
Applied neuropsychology: Adult 2025 DOI
Robin Ziyue,
Stefan,
Bjørn-Eivind,
Britt,
Marie,
Alenka
et al.:
Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer's disease
EBioMedicine 2025 DOI
Mostafa Mehdipour,
Per,
Santiago Timon,
Sandra Raquel Ramos,
Silvia,
Atle
et al.:
Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts
Julia Kristine,
Fernando,
Thomas,
Bjørn-Eivind Seljelid,
Katrin,
Henrik
et al.:
Neuronal plasma biomarkers in acute ischemic stroke
Anders,
Bjørn-Eivind Seljelid,
Santiago Timon,
Ellen,
Per,
Jaka
et al.:
Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project
Cecilia Magdalena,
Bjørn-Eivind Seljelid,
Ragna,
Nikias Ioannis,
Knut,
Arvid
et al.:
Depressive Symptoms Are Not Associated with Predementia Cerebrospinal Fluid Amyloid Pathology
Sofia Egebäck,
Robin Ziyue,
Bjørn-Eivind Seljelid,
Alenka,
Tormod,
Bengt
et al.:
Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases
Journal of Alzheimer's Disease 2024 DOI
Fernando,
Thomas K.,
Danielle Taylor-Te,
Dawn,
Bjørn-Eivind Seljelid,
Tormod
et al.:
Plasma phosphorylated-tau217 is increased in Niemann–Pick disease type C
Fernando,
Bjørn-Eivind Seljelid,
José,
Jordan E.,
Per,
Berglind
et al.:
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
Stephanie,
Kaja,
Gøril Rolfseng,
Jonas Alexander,
Ingvild Vøllo,
Per
et al.:
Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer’s Disease
Giuseppe Mario,
Fernando,
Simone,
Bjørn-Eivind Seljelid,
Andrea,
Angela
et al.:
Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease
Kaja,
Bjørn-Eivind Seljelid,
Grit,
Lene,
Berglind,
Nikias Ioannis
et al.:
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Fredrik,
Marie,
Erik,
Johan Jacob,
Ingvild Vøllo,
Ingrid Myrvoll
et al.:
Demographically adjusted Rey–Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49–77 years and comparison with North American norms
Mathilde Suhr,
Luiza,
Monica Haraldseid,
Berglind,
Gøril Rolfseng,
Arne Exner
et al.:
Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults
Johan Jacob,
Ingrid Myrvoll,
Ingvild Vøllo,
Erik,
Knut K,
Santiago
et al.:
Regression-based normative data for the D-KEFS Color-Word Interference Test in Norwegian adults ages 20–85
Therese Händel,
Bjørn-Eivind,
Carsten,
Anders,
Marie,
Tormod
et al.:
Improving validity of the trail making test with alphabet support
Jonas Alexander,
Atle,
Turi Olene,
Mehdi Sadat,
Bjørn-Eivind,
Lene
et al.:
Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort
Ingrid Myrvoll,
Johan Jacob,
Ingvild Vøllo,
Erik,
Knut K,
Arne Exner
et al.:
Investigating the relationship between allocentric spatial working memory and biomarker status in preclinical and prodromal Alzheimer’s disease
Klaus Thanke,
Jan,
Trygve,
Kaj,
Henrik,
Bjørn-Eivind Seljelid
et al.:
CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred
Santiago,
Mariano,
Rafael,
Bjørn-Eivind Seljelid,
Tormod
:
A Knowledge Graph Framework for Dementia Research Data
Bjørn-Eivind,
Grit,
Kaja,
Dag,
Geir,
Betty M
et al.:
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
Ingvild Vøllo,
Bjørn-Eivind,
Tormod,
Knut,
Sigrid Botne,
Mathilde Suhr
et al.:
Regression-Based Cognitive Change Norms Applied in Biochemically Defined Predementia Alzheimer’s Disease
Jacob,
Ingvild Vøllo,
Fredrik,
Erik,
Knut K,
Marie
et al.:
Regression‐based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults aged 49–79 and comparison with published norms
Miguel Germán,
Daniel,
Per,
Diego Alejandro,
Alberto,
Bjørn-Eivind
et al.:
Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness
Ingrid Myrvoll,
Johan Jacob,
Erik,
Knut,
Geir,
Santiago
et al.:
Regression-based norms for the FAS phonemic fluency test for ages 40–84 based on a Norwegian sample
Nikias Ioannis,
Bjørn-Eivind,
Deepak P,
Cecilia Magdalena,
Eirik,
Erik
et al.:
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
Johan Jacob,
Erik,
Ingvild Vøllo,
Knut,
Marie,
Sigrid Botne
et al.:
Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years
Ingvild Vøllo,
Tormod,
Bjørn-Eivind,
Knut,
Marie,
Anders
et al.:
Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia
Anne Katrine,
Petroula,
Bjørn-Eivind,
Hogne,
Abdul,
Alf Inge
et al.:
Exploration of plasma lipids in mild cognitive impairment due to Alzheimer's disease
Journal of Alzheimer's Disease 2020 DOI
Ragna,
Bjørn-Eivind,
Cecilia Magdalena,
Knut K,
Erik,
Stein Harald
et al.:
Amyloid plaques and symptoms of depression links to medical help-seeking due to subjective cognitive decline
Erik,
Bjørn-Eivind,
Cecilia Magdalena,
Carl Fredrik Andestad,
Arne,
Geir
et al.:
In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
Bjørn-Eivind,
Ragna,
Erik,
Knut,
Stein Harald,
Elisabeth
et al.:
Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years
Mathilde Suhr,
Monica Haraldseid,
Berglind,
Gøril Rolfseng,
Arne Exner,
Tormod
et al.:
Cerebrospinal fluid neurofilament light chain mediates age-related decline in learning and memory in healthy adults
2023
Luiza,
Monica Haraldseid,
Bjørn-Eivind,
Per,
John Christian Jøraholmen,
Anne Brita
et al.:
The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
Nikias Ioannis,
Bjørn-Eivind,
Deepak P.,
Cecilia Magdalena,
Eirik,
Erik
et al.:
Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression (Scientific Reports, (2021), 11, 1, (20375), 10.1038/s41598-021-99794-9)
Scientific Reports 2022 DOI
Johan Jacob,
Ingvild Vøllo,
Tormod,
Marie,
Wallin,
Knut
et al.:
Demographically adjusted test norms for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults
from 41 to 79 years
2020
Bjørn-Eivind
:
Hva vet vi om Alzheimers sykdom i dag, og finnes det en kur?
21. septiembre 2020
Bjørn-Eivind
:
Tromsø-forskere jobber intenst med å løse alzheimer-gåten
28. diciembre 2019
Johan Jacob,
Bjørn-Eivind,
Ingvild Eliassen,
Ragna,
Knut,
Erik
et al.:
Demographically adjusted norms for basic and derived measures on the Trail Making Test A & B based on a Norwegian sample age 40 – 84 years.
2019
Bjørn-Eivind,
Tine Viktoria
:
Forsker på demens: – Antioksidanter fra blåbær kan bidra til å bremse demens
07. agosto 2019
Bjørn-Eivind
:
Frykter fordobling av demenstilfeller innen 2050: Tromsø-forskere undersøker om blåbær kan være kuren
14. agosto 2019
Bjørn-Eivind
:
Vil avdekke Alzheimers sykdom så tidlig som mulig
05. junio 2019
Bjørn-Eivind,
Per,
Grit,
Berglind,
Marianne,
Silje Bøen
et al.:
Cerebrospinal fluid Neurogranin/BACE1 ratio differentiate normal controls, pre-dementia Alzheimer’s and Parkinson’s disease cases.
2019
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Klinisk nevropsykologi og regresjonsbaserte normer. Preklinisk og prodromal Alzheimers sykdom.
